Infant markers for mental health, self-regulation, developmental status, and behavioral problems Pregnancy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • pregnant women between 8+0 to 14+0 weeks of pregnancy • pregnant women who have signed the informed consent • pregnant women who agree to take part in the examinations (blood, urine, second-to-fourth finger length ratio [2D:4D], heart rate variability, questionnaires, examination of the child, etc.) • pregnant women who agree to use the app • pregnant women with an unproblematic pregnancy at the time of inclusion
Exclusion criteria
Exclusion criteria: • multiple pregnancy • manifest comprehension problems during the introductory briefing • prior severe psychiatric illness • past history of adverse or missing effects of mindfulness exercises
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Second-to-fourth finger length ratio (2D:4D) in the 11- to 12-month-old child | — |
Secondary
| Measure | Time frame |
|---|---|
| Child (birth and 11- to 12-month of age): Index “Orientation and Regulation“ of the Infant Behavior Questionnaire Revised (IBQ-R); subscale scores of the German Parent Questionnaire of Child Development supplement to the Pediatric Screenings (EEE U6); subscale scores cognition, language, and motor function of the Bayley Scales of Infant and Toddler Development (BSID); sum and subscale scores of the Child Behavior Checklist (CBCL); infant anogenital distance; strength of the transient-evoked otoacoustic emissions (TEOAEs); ethylglucuronide (EtG) in meconium. Mother (longitudinal): Sum and subscale scores of the Perceived Stress Scale (PSS10); sum scale score of the Pregnancy Related Anxiety Questionnaire (PRAQ-R2); sum and subscale scores of the Mindful Attention and Awareness Scale (MAAS) and the Five Facet-Mindfulness Questionnaire (FFMQ-D); consumption quantified by the modified Alcohol Use Disorder Identification Test (AUDIT-C); consumption quantified by the modified smoking questionnaire Robert Koch-Institut; cotinine in maternal hair; ethylglucuronide (EtG) in maternal hair; cortisol in maternal hair. | — |
Countries
Germany
Contacts
Universitätsklinikum Erlangen, Psychiatrische und Psychotherapeutische Klinik